Inhaled nitric oxide in persistent pulmonary hypertension of the newborn: usage protocol in a specialized pediatric institute in Latin America
Óxido nítrico inhalado en hipertensión pulmonar persistente del recién nacido: protocolo de uso en un instituto pediátrico especializado de Latinoamérica
##plugins.themes.bootstrap3.article.sidebar##
PDF (Español (España))
FLIP
##plugins.themes.bootstrap3.article.main##
The use of inhaled nitric oxide is part of the therapeutic strategies in the newborn with severe pulmonary pathology associated with pulmonary hypertension. The nitric oxide allows an improvement in oxigenation by promoting pulmonary vasodilation. As inclusion criteria we have pulmonary hypertension diagnosed by echocardiography and hypoxemic respiratory failure. Patients with left ventricular dysfunction, intracraneal hemorrhage, chromosomopathies or malformations incompatible with life are not eligible. The objective of our publication is to describe our protocol for the use of inhaled nitric oxide in pulmonary hypertension of the newborn at “Instituto Nacional del Niño-San Borja”, in Lima Perú
Downloads
##plugins.themes.bootstrap3.article.details##
Respaldiza-Salas MN, Carlos-Gil AN, Navarro-Palenzuela C, RosarioLozano MP, Benot-López S. Óxido nítrico como tratamiento de la hipertensión pulmonar en prematuros. Informes de evaluación de tecnologías sanitarias. Sevilla: Agencia de Evaluación de Tecnologías Sanitarias de Andalucía, 2015.
Carrera Muiños S, Cano Villalpando C, Fernández Carrocera L, Cordero González G, Corral Kassian E, Barrera Martínez I, et al. Uso de óxido nítrico inhalado en la hipertensión pulmonar persistente del recién nacido. Perinatol Reprod Hum. 2016;30(2):69–74. doi: 10.1016/j.rprh.2016.06.007
López-Herce J, Carrillo A. Óxido nítrico: indicaciones en pediatría. An Pediatr Contin. 2005;3(1):40–3. doi: 10.1016/S1696-2818(05)74764-8
Barrington KJ, Finer N, Pennaforte T, Altit G. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2017;1(1):CD000399. doi:10.1002/14651858.CD000399.pub3
Nair J, Lakshminrusimha S. Update on PPHN: mechanisms and treatment. Semin Perinatol. 2014;38(2):78-91. doi: 10.1053/j.semperi.2013.11.004
American Academy of Pediatrics. Committee on Fetus and Newborn. Use of inhaled nitric oxide. Pediatrics. 2000;106(2 Pt 1):344-5.
Figueras Aloy J, Castillo Salinas F, Elorza Fernández D, Sánchez-Luna M, Pérez Rodríguez J, Doménech E, et al. Recomendaciones para la utilización del óxido nítrico inhalado en patología neonatal. An Pediatr (Barc). 2006;64(3):260–5.
Golombek S, Sola A, Lemus L; Miembros del Consenso de SIBEN. Recomendaciones del VI Consenso Clínico de SIBEN para la Hipertensión Pulmonar Persistente del Recién Nacido. NeoReviews. 2017;18(5):e327–44. doi: 10.1542/neo.18-5-e327
Macrae DJ, Field D, Mercier JC, Møller J, Stiris T, Biban P, et al. Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Intensive Care Med. 2004;30(3):372-80. doi: 10.1007/s00134-003-2122-3
Kumar P; Committee on Fetus and Newborn; American Academy of Pediatrics. Use of inhaled nitric oxide in preterm infants. Pediatrics. 2014;133(1):164-70. doi: 10.1542/peds.2013-3444
Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD; NO CLD Study Group. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med. 2006;355(4):343-53. doi:10.1056/NEJMoa061088
Kinsella JP, Steinhorn RH, Krishnan US, Feinstein JA, Adatia I, Austin ED, et al. Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension. J Pediatr. 2016;170:312-4. doi: 10.1016/j.jpeds.2015.11.050
Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr. 2000;136(5):611-7. doi: 10.1067/mpd.2000.104826
Nelin LD, Potenziano JL. Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response. BMC Pediatr. 2019;19(1):17. doi:10.1186/s12887-018-1368-4
Blasina F, Vaamonde L, Silvera F, Solla G, Abin-Carriquiry JA, Gutiérrez C, et al. Efficacy and safety of a novel nitric oxide generator for the treatment of neonatal pulmonary hypertension: Experimental and clinical studies. Pulm Pharmacol Ther. 2019;54:68-76. doi: 10.1016/j. pupt.2018.12.002
Campbell BT, Herbst KW, Briden KE, Neff S, Ruscher KA, Hagadorn JI. Inhaled nitric oxide use in neonates with congenital diaphragmatic hernia. Pediatrics. 2014;134(2):e420-6. doi:10.1542/peds.2013-2644
Elmekkawi A, More K, Shea J, Sperling C, da Silva Z, Finelli M, et al. Impact of Stewardship on Inhaled Nitric Oxide Utilization in a Neonatal ICU. Hosp Pediatr. 2016;6(10):607-15. doi:10.1542/hpeds.2016-0003
Peliowski A; Canadian Paediatric Society, Fetus and Newborn Committee. Inhaled nitric oxide use in newborns. Paediatr Child Health. 2012;17(2):95-100. doi:10.1093/pch/17.2.9
